Skip to content
← Back to this collection

PUBLICATIONS · 26101246

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Aug 10
First author
O'Connor OA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      O'Connor OA
      type
      Author
    2. name
      Horwitz S
      type
      Author
    3. name
      Masszi T
      type
      Author
    4. name
      Van Hoof A
      type
      Author
    5. name
      Brown P
      type
      Author
    6. name
      Doorduijn J
      type
      Author
    7. name
      Hess G
      type
      Author
    8. name
      Jurczak W
      type
      Author
    9. name
      Knoblauch P
      type
      Author
    10. name
      Chawla S
      type
      Author
    11. name
      Bhat G
      type
      Author
    12. name
      Choi MR
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      O'Connor OA
      type
      Author
    2. name
      Horwitz S
      type
      Author
    3. name
      Masszi T
      type
      Author
    4. name
      Van Hoof A
      type
      Author
    5. name
      Brown P
      type
      Author
    6. name
      Doorduijn J
      type
      Author
    7. name
      Hess G
      type
      Author
    8. name
      Jurczak W
      type
      Author
    9. name
      Knoblauch P
      type
      Author
    10. name
      Chawla S
      type
      Author
    11. name
      Bhat G
      type
      Author
    12. name
      Choi MR
      type
      Author
    bibliography ids
    1. nci-bib-53e7034d71c3228bfbec1219
    book metadata
    content sha256
    a90ebbe3c1d55217c9091b1900bad21b12efe68def3ebd84327eaea47ca99708
    document type
    citation
    dois
    1. 10.1200/JCO.2014.59.2782
    electronic publication date
    display
    2015 Jun 22
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26101246
    immutable id
    pubmed:26101246@a90ebbe3c1d55217c9091b1900bad21b12efe68def3ebd84327eaea47ca99708
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    23
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2492-9
    volume
    33
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26101246
      provenance
      batch id
      4c1ece5bfc3d8e2be622
      provider
      NCBI PubMed ESummary
      record sha256
      e3e4785fcae80fa61774c20db5ffe734e2b5255a9ef71dc0539b0974708c9289
      response sha256
      85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
      retrieved at
      2026-09-09T23:47:12.730551+00:00
      publication date
      display
      2015 Aug 10
      precision
      day
      year
      2015
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26101246/
      title
      Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

      Preserved source evidence · Independent clinical review pending · Not medical advice